Production (Stage)
Processa Pharmaceuticals, Inc.
PCSA
$0.3006
$0.01033.55%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.90M | 1.19M | 2.89M | 5.57M | 8.92M |
| Total Receivables | -- | -- | -- | -- | 22.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 860.80K | 682.30K | 1.95M | 1.91M | 857.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 3.76M | 1.87M | 4.84M | 7.48M | 9.80M |
|
|
|||||
| Total Current Assets | 3.76M | 1.87M | 4.84M | 7.48M | 9.80M |
| Net Property, Plant & Equipment | 52.50K | 75.70K | 98.50K | 117.50K | 138.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 999.20K | 1.28M | 5.50K | 5.50K | 5.50K |
| Total Assets | 4.81M | 3.23M | 4.94M | 7.60M | 9.94M |
|
|
|||||
| Total Accounts Payable | 552.60K | 880.90K | 711.70K | 953.10K | 455.40K |
| Total Accrued Expenses | 680.70K | 578.70K | 412.80K | 505.40K | 465.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 49.70K | 73.00K | 94.70K | 93.20K | 89.70K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.28M | 1.53M | 1.22M | 1.55M | 1.01M |
|
|
|||||
| Total Current Liabilities | 1.28M | 1.53M | 1.22M | 1.55M | 1.01M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 500.00 | 2.20K | 25.60K | 50.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.28M | 1.53M | 1.22M | 1.58M | 1.06M |
|
|
|||||
| Common Stock & APIC | 93.88M | 89.22M | 88.51M | 87.43M | 87.28M |
| Retained Earnings | -90.05M | -87.22M | -84.49M | -81.11M | -78.10M |
| Treasury Stock & Other | -300.00K | -300.00K | -300.00K | -300.00K | -300.00K |
| Total Common Equity | 3.53M | 1.70M | 3.72M | 6.02M | 8.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.53M | 1.70M | 3.72M | 6.02M | 8.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.53M | 1.70M | 3.72M | 6.02M | 8.88M |
|
|
|||||